This ADC product is comprised of an anti-EGFR monoclonal antibody conjugated via a Mc linker to MMAF. The MMAF is targeted to EGFR-positive cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, M
* VAT and and shipping costs not included. Errors and price changes excepted